Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body. For more information, please visit the company’s website at www.nkartatx.com.
Location: United States, California, South San Francisco
Member count: 51-200
Total raised: $114M
Founded date: 2015
Investors 5
Date | Name | Website |
07.08.2021 | New Enterp... | nea.com |
- | Logos Capi... | logoscapit... |
- | RA Capital... | racap.com |
- | Life Scien... | lspvc.com |
- | SR One | srone.com |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
06.09.2019 | Series B | $114M | - | fiercebiot... |
Mentions in press and media 8
Date | Title | Description | Category | Author | Source |
11.09.2019 | Biopharmac... | Biopharmaceutical company Nkar... | - | - | pulse2.com... |
06.09.2019 | Nkarta The... | Nkarta Therapeutics, a South S... | USA | - | finsmes.co... |
05.09.2019 | Nkarta The... | SOUTH SAN FRANCISCO, CA, Nka... | - | - | vcnewsdail... |
04.09.2019 | Nkarta net... | Amgen Ventures and Deerfield M... | Biotech | - | fiercebiot... |
04.09.2019 | Nkarta net... | Amgen Ventures and Deerfield M... | Biotech | - | fiercebiot... |
30.07.2019 | Pharma lea... | When I was 13 years old, my do... | - | - | statnews.c... |
14.12.2018 | Shinichi T... | → Jeff Abbey is jumping to th... | - | Amber Tong | endpts.com... |
- | Nkarta’s n... | The first cell therapies for c... | - | - | medcitynew... |